SCHEDULE 13G Filed 2026-06-26 Event — SEC 0001376474-26-000460 →

Feis Equities LLC → Drugs Made In America Acquisition Corp. DMAAR

Stake: — Shares: — CUSIP: G2847J104 Class: Ordinary share ($0.0001 par value)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

14 filings by this filer

13 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 5.49

61,118 shares short · -31.0% vs prior

Other Filings by Feis Equities LLC

Filed	Form	Issuer	Stake	Shares
2026-10-09	SCHEDULE 13G	Pine Tree Acquisition Corp.	—	—	view →
2026-08-28	SCHEDULE 13G	Southern Cross Acquisition II Corp.	—	—	view →
2026-08-27	SCHEDULE 13G	OceanLight Acquisition Corp	—	—	view →
2026-08-25	SCHEDULE 13G/A	Alpex Acquisition Corp	—	—	view →
2026-08-24	SCHEDULE 13G/A	BOA Acquisition Corp. II	—	—	view →
2026-08-07	SCHEDULE 13G	BOA Acquisition Corp. II	—	—	view →
2026-07-02	SCHEDULE 13G	Futurewave Acquisition Corp FWACU	—	—	view →
2026-07-02	SCHEDULE 13G	Alpex Acquisition Corp ALPXU	—	—	view →
2026-06-18	SCHEDULE 13G	JAB Acquisition Corp I JABRU	—	—	view →
2026-06-11	SCHEDULE 13G	Aeon Acquisition I Corp. AESPW	—	—	view →
2026-06-08	SCHEDULE 13G/A	Quartzsea Acquisition Corp QSEAU	—	—	view →
2026-05-27	SCHEDULE 13G	Aperture AC APURR	—	—	view →
2026-05-27	SCHEDULE 13G	Peace Acquisition Corp. PECEU	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →